Singapore, Oct. 28 -- Singapore-based Raffles Medical Group and Gene Solutions, headquartered in Vietnam, have signed a Memorandum of Understanding (MoU) to streamline patient recruitment for oncology clinical trials, marking a significant milestone in advancing precision medicine in Southeast Asia.

Under this partnership,theRaffles Medical Group and Gene Solutions will collaborate to identify patients eligible for pharma-sponsored clinical trials. Patients undergoing Comprehensive Genomic Profiling (CGP) via Gene Solutions will be automatically screened for eligibility.

Raffles Medical Group's Clinical Trials Unit will collaborate closely with local oncologists to facilitate patient enrolment. This initiative aims to make cutting-edge ...